ZA883239B - A multi-layer pharmaceutical composition - Google Patents
A multi-layer pharmaceutical compositionInfo
- Publication number
- ZA883239B ZA883239B ZA883239A ZA883239A ZA883239B ZA 883239 B ZA883239 B ZA 883239B ZA 883239 A ZA883239 A ZA 883239A ZA 883239 A ZA883239 A ZA 883239A ZA 883239 B ZA883239 B ZA 883239B
- Authority
- ZA
- South Africa
- Prior art keywords
- pharmaceutical composition
- layer pharmaceutical
- layer
- composition
- pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI872051A FI77573C (fi) | 1987-05-08 | 1987-05-08 | Ny konsistens. |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA883239B true ZA883239B (en) | 1989-07-26 |
Family
ID=8524451
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA883239A ZA883239B (en) | 1987-05-08 | 1988-05-05 | A multi-layer pharmaceutical composition |
Country Status (35)
Country | Link |
---|---|
US (1) | US4935247A (fi) |
JP (1) | JPS63287720A (fi) |
KR (1) | KR880013551A (fi) |
AT (1) | AT396329B (fi) |
AU (1) | AU610161B2 (fi) |
BE (1) | BE1000785A3 (fi) |
CH (1) | CH675070A5 (fi) |
CS (1) | CS270588B2 (fi) |
DD (1) | DD284600A5 (fi) |
DE (1) | DE3815562A1 (fi) |
DK (1) | DK247588A (fi) |
EG (1) | EG18603A (fi) |
ES (1) | ES2006649A6 (fi) |
FI (1) | FI77573C (fi) |
FR (1) | FR2630912B1 (fi) |
GB (1) | GB2204241B (fi) |
GR (1) | GR1000303B (fi) |
HU (1) | HU198621B (fi) |
IL (1) | IL86313A (fi) |
IS (1) | IS3339A7 (fi) |
IT (1) | IT1219691B (fi) |
LU (1) | LU87208A1 (fi) |
MA (1) | MA21264A1 (fi) |
MX (1) | MX167185B (fi) |
NL (1) | NL8801185A (fi) |
NO (1) | NO881993L (fi) |
NZ (1) | NZ224529A (fi) |
PH (1) | PH24652A (fi) |
PL (1) | PL272295A1 (fi) |
PT (1) | PT87429B (fi) |
RO (1) | RO101402B (fi) |
RU (1) | RU1836082C (fi) |
SE (1) | SE8801732L (fi) |
YU (1) | YU46457B (fi) |
ZA (1) | ZA883239B (fi) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH01299226A (ja) * | 1988-05-27 | 1989-12-04 | Seikagaku Kogyo Co Ltd | サラゾスルファピリジン腸溶顆粒 |
NO882653D0 (no) * | 1988-06-15 | 1988-06-15 | Apothekernes Lab | Doseringsform. |
US5296236A (en) * | 1988-09-16 | 1994-03-22 | Recordati S.A., Chemical And Pharmaceutical Company | Controlled release therapeutic system for a liquid pharmaceutical formulations |
US5055307A (en) * | 1988-12-29 | 1991-10-08 | Asahi Kagaku Kogyo Kabushiki Kaisha | Slow release drug delivery granules and process for production thereof |
US5093128A (en) * | 1989-07-18 | 1992-03-03 | Draguesku Oliver J | Rumen and other stomach chamber bypass nutrients and methods of fabrication |
JP3078859B2 (ja) * | 1990-02-23 | 2000-08-21 | 武田薬品工業株式会社 | 安定な放出制御性製剤用コーティング剤 |
US5084287A (en) * | 1990-03-15 | 1992-01-28 | Warner-Lambert Company | Pharmaceutically useful micropellets with a drug-coated core and controlled-release polymeric coat |
DE4200821A1 (de) * | 1992-01-15 | 1993-07-22 | Bayer Ag | Geschmacksmaskierte pharmazeutische mittel |
GB9201639D0 (en) * | 1992-01-25 | 1992-03-11 | Smithkline Beecham Plc | Pharmaceutical formulations |
EP0689840A1 (de) * | 1994-06-28 | 1996-01-03 | Spirig Ag Pharmazeutische Präparate | Neues orales Erythromycinbase enthaltendes Arzneimittel |
US20020035071A1 (en) * | 1997-07-08 | 2002-03-21 | Josef Pitha | Mimicking the metabolic effects of caloric restriction by administration of glucose antimetabolites |
US20060116330A1 (en) * | 1997-07-08 | 2006-06-01 | The Iams Company | Methods of mimicking the metabolic effects of caloric restriction by administration of mannoheptulose |
US8563522B2 (en) * | 1997-07-08 | 2013-10-22 | The Iams Company | Method of maintaining and/or attenuating a decline in quality of life |
US6242019B1 (en) | 1997-08-14 | 2001-06-05 | Warner-Lambert Company | Taste modified hard confectionery compositions containing functional ingredients |
FR2821745B1 (fr) * | 2001-03-09 | 2004-07-02 | Ethypharm Lab Prod Ethiques | Granules et granules enrobes au gout masque |
FR2821747B1 (fr) * | 2001-03-09 | 2004-07-02 | Ethypharm Lab Prod Ethiques | Suspension de telithromycine a gout masque |
US8168170B2 (en) * | 2002-10-03 | 2012-05-01 | The Procter And Gamble Company | Compositions having an inner core and at least three surrounding layers |
US8894991B2 (en) * | 2003-12-19 | 2014-11-25 | The Iams Company | Canine probiotic Lactobacilli |
US8877178B2 (en) | 2003-12-19 | 2014-11-04 | The Iams Company | Methods of use of probiotic bifidobacteria for companion animals |
US20050152884A1 (en) * | 2003-12-19 | 2005-07-14 | The Procter & Gamble Company | Canine probiotic Bifidobacteria globosum |
US20050158294A1 (en) * | 2003-12-19 | 2005-07-21 | The Procter & Gamble Company | Canine probiotic Bifidobacteria pseudolongum |
US7785635B1 (en) | 2003-12-19 | 2010-08-31 | The Procter & Gamble Company | Methods of use of probiotic lactobacilli for companion animals |
US20050202079A1 (en) * | 2004-03-15 | 2005-09-15 | Mylan Pharmaceuticals Inc. | Novel orally administrable formulation of nitrofurantoin and a method for preparing said formulation |
WO2006130187A1 (en) * | 2005-05-31 | 2006-12-07 | The Iams Company | Feline probiotic lactobacilli |
BRPI0611492B1 (pt) * | 2005-05-31 | 2021-10-13 | Mars, Incorporated | Bifidobactéria probiótica felina |
CN101711158A (zh) | 2007-02-01 | 2010-05-19 | 爱默思公司 | 使用葡萄糖抗代谢物、鳄梨或鳄梨提取物减轻哺乳动物炎症和应激反应的方法 |
US9771199B2 (en) | 2008-07-07 | 2017-09-26 | Mars, Incorporated | Probiotic supplement, process for making, and packaging |
US10104903B2 (en) | 2009-07-31 | 2018-10-23 | Mars, Incorporated | Animal food and its appearance |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE835500C (de) * | 1950-05-18 | 1952-03-31 | Otto Doerr Dipl Ing | Verfahren zum Konservieren eines in einem indifferenten Koerper gespeicherten, im Darm zur Wirkung zu bringenden Mittels |
US2828206A (en) * | 1954-02-24 | 1958-03-25 | Roseuberg Adolf | Stabilized fat-soluble vitamins and methods of making same |
US2963402A (en) * | 1955-01-18 | 1960-12-06 | Nysco Lab Inc | Sustained release medicament |
GB821790A (en) * | 1956-11-20 | 1959-10-14 | Smith Kline French Lab | Method of preparing sustained release particles and the product of the method |
US2921883A (en) * | 1957-05-03 | 1960-01-19 | Smith Kline French Lab | Novel coating material for medicaments |
NL270408A (fi) * | 1960-10-20 | |||
NL297088A (fi) * | 1961-01-31 | |||
BE640616A (fi) * | 1962-12-19 | |||
US3256153A (en) * | 1963-02-08 | 1966-06-14 | Smith Kline French Lab | Method of stabilizing wax-fat coating materials and product thereof |
US3432593A (en) * | 1963-09-18 | 1969-03-11 | Key Pharm Inc | Delayed and sustained release type pharmaceutical preparation |
US4330338A (en) * | 1978-10-02 | 1982-05-18 | Purdue Research Foundation | Pharmaceutical coating composition, and preparation and dosages so coated |
IT1148784B (it) * | 1980-04-09 | 1986-12-03 | Eurand Spa | Procedimento per la preparazione di microcapsule in un veicolo liquido |
NZ210785A (en) * | 1984-01-13 | 1987-11-27 | Battelle Development Corp | Liquid dispersions of layered controlled release dosage forms |
US4650665A (en) * | 1985-02-08 | 1987-03-17 | Ethicon, Inc. | Controlled release of pharmacologically active agents from an absorbable biologically compatible putty-like composition |
HU207452B (en) * | 1986-03-21 | 1993-04-28 | Eurasiam Lab | Method for producing therapeutical preparations containing active ingredient having biologicallu active protein structure |
-
1987
- 1987-05-08 FI FI872051A patent/FI77573C/fi not_active IP Right Cessation
-
1988
- 1988-04-25 YU YU83188A patent/YU46457B/sh unknown
- 1988-04-27 MX MX011281A patent/MX167185B/es unknown
- 1988-05-05 EG EG250/88A patent/EG18603A/xx active
- 1988-05-05 ZA ZA883239A patent/ZA883239B/xx unknown
- 1988-05-06 HU HU882313A patent/HU198621B/hu not_active IP Right Cessation
- 1988-05-06 KR KR1019880005287A patent/KR880013551A/ko not_active Application Discontinuation
- 1988-05-06 IT IT20479/88A patent/IT1219691B/it active
- 1988-05-06 RO RO133416A patent/RO101402B/ro unknown
- 1988-05-06 GB GB8810765A patent/GB2204241B/en not_active Expired - Fee Related
- 1988-05-06 RU SU884355822A patent/RU1836082C/ru active
- 1988-05-06 ES ES8801414A patent/ES2006649A6/es not_active Expired
- 1988-05-06 PL PL27229588A patent/PL272295A1/xx unknown
- 1988-05-06 CS CS883102A patent/CS270588B2/cs unknown
- 1988-05-06 GR GR880100297A patent/GR1000303B/el unknown
- 1988-05-06 NZ NZ224529A patent/NZ224529A/xx unknown
- 1988-05-06 MA MA21505A patent/MA21264A1/fr unknown
- 1988-05-06 BE BE8800509A patent/BE1000785A3/fr not_active IP Right Cessation
- 1988-05-06 AT AT0119188A patent/AT396329B/de not_active IP Right Cessation
- 1988-05-06 SE SE8801732A patent/SE8801732L/ not_active Application Discontinuation
- 1988-05-06 DK DK247588A patent/DK247588A/da not_active Application Discontinuation
- 1988-05-06 DE DE3815562A patent/DE3815562A1/de not_active Withdrawn
- 1988-05-06 DD DD88315493A patent/DD284600A5/de not_active IP Right Cessation
- 1988-05-06 NL NL8801185A patent/NL8801185A/nl not_active Application Discontinuation
- 1988-05-06 AU AU15672/88A patent/AU610161B2/en not_active Ceased
- 1988-05-06 LU LU87208A patent/LU87208A1/fr unknown
- 1988-05-06 NO NO881993A patent/NO881993L/no unknown
- 1988-05-06 PH PH36902A patent/PH24652A/en unknown
- 1988-05-06 PT PT87429A patent/PT87429B/pt not_active IP Right Cessation
- 1988-05-06 IS IS3339A patent/IS3339A7/is unknown
- 1988-05-06 JP JP63111344A patent/JPS63287720A/ja active Pending
- 1988-05-06 FR FR888806173A patent/FR2630912B1/fr not_active Expired - Fee Related
- 1988-05-06 US US07/191,190 patent/US4935247A/en not_active Expired - Fee Related
- 1988-05-06 CH CH1739/88A patent/CH675070A5/de not_active IP Right Cessation
- 1988-05-09 IL IL86313A patent/IL86313A/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA883239B (en) | A multi-layer pharmaceutical composition | |
GB2204792B (en) | Pharmaceutical composition | |
ZA883167B (en) | Pharmaceutical composition | |
ZA895838B (en) | Pharmaceutical compounds | |
AU101932S (en) | A pharmaceutical tablet | |
GB8800891D0 (en) | Pharmaceutical compounds | |
GB8825892D0 (en) | Pharmaceutical composition | |
IL87943A (en) | Pharmaceutical compositions containing a piperidinoalkanol-decongestant combination | |
IE872126L (en) | Pharmaceutical compounds | |
GB8711408D0 (en) | Pharmaceutical compound | |
GB8830078D0 (en) | Pharmaceutical compounds | |
GB8826204D0 (en) | Pharmaceutical compounds | |
GB8725648D0 (en) | Pharmaceutical composition | |
GB8708041D0 (en) | Pharmaceutical composition | |
IE872168L (en) | Pharmaceutical composition | |
GB8720401D0 (en) | Pharmaceutical composition | |
GB8718907D0 (en) | Pharmaceutical composition | |
ZA883400B (en) | Pharmaceutical composition | |
GB8716574D0 (en) | Pharmaceutical composition | |
ZA881474B (en) | Pharmaceutical composition | |
GB8707739D0 (en) | Pharmaceutical composition | |
GB8705900D0 (en) | Pharmaceutical composition | |
GB8725055D0 (en) | Pharmaceutical composition | |
IE872788L (en) | Pharmaceutical combination | |
IE870641L (en) | Pharmaceutical combinations |